Yu Lai
Impact in
-
- HIV Research and Treatment
Papers in
-
- Natural product bioactivities and synthesis 2
- Virology 5
- HIV Research and Treatment 5
- Co-authors
- Wei Huang (2 shared papers)Xinyun Li (1 shared paper)Yanxi Liu (2 shared papers)Jingyi Ding (2 shared papers)Yingchao Zhu (1 shared paper)Jiahang Zhou (1 shared paper)Sujuan Liu (1 shared paper)Fang Lei (1 shared paper)
- Journals
- Heliyon (4 papers)Current Stem Cell Research & Therapy (2 papers)Frontiers in Immunology (2 papers)Current HIV Research (2 papers)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yu Lai
27 papers receiving 244 citations
Peers
Comparison fields: 5 of 89
- Virology 19
- Biological Psychiatry 9
- Toxicology 6
- Pharmacology 13
- Anesthesiology and Pain Medicine 7
Countries citing papers authored by Yu Lai
This map shows the geographic impact of Yu Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lai more than expected).
Fields of papers citing papers by Yu Lai
This network shows the impact of papers produced by Yu Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lai. The network helps show where Yu Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 64 | |
| 2 | 2015 | 25 | |
| 3 | 2020 | 18 | |
| 4 | 2024 | 15 | |
| 5 | 2021 | 14 | |
| 6 | 2023 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2021 | 10 | |
| 9 | 2012 | 10 | |
| 10 | Prophylactic use of gentamicin/flucloxacillin versus cefuroxime in surgery: a meta analysis of clinical studies. | 2015 | 8 |
| 11 | 2023 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Yu Lai
Yu Lai is a scholar working on Molecular Biology, Virology, Infectious Diseases, Oncology and Surgery, having authored 30 papers that have together received 245 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (2 papers), Natural product bioactivities and synthesis (2 papers), Mycobacterium research and diagnosis (2 papers), Immunotherapy and Immune Responses (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Agricultural risk and resilience (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Virology (19 citations), Biological Psychiatry (9 citations), Toxicology (6 citations), Pharmacology (13 citations) and Anesthesiology and Pain Medicine (7 citations). Yu Lai has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Wei Huang, Xinyun Li, Yanxi Liu, Jingyi Ding, Yingchao Zhu, Jiahang Zhou, Sujuan Liu, Fang Lei, Lushuang Xie and Ting‐Hua Wang. Their work appears in journals such as Heliyon, Current Stem Cell Research & Therapy, Frontiers in Immunology, Current HIV Research and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.